Gary Shapiro

Company: Affini-T Therapeutics

Job title: Vice President, Discovery Biology

Seminars:

Affini-T Platform Technologies Enable the Generation of Potent & Tolerable TCR-T Cells 2:45 pm

• TAILOR TCR discovery platform uses predictive algorithms to identify highly functional and specific TCRs against diverse targets • TUNE synthetic biology platform programs cell persistence in the TME to enhance durability with switch receptors, co-receptors, and other armoring technologies • THRIVE engineering and manufacturing platform allows for scalable manufacturing with gene editing technologies to…Read more

day: Day 2